Literature DB >> 115037

A rating scale for tardive dyskinesia.

G M Simpson, J H Lee, B Zoubok, G Gardos.   

Abstract

A rating scale for tardive dyskinesia was developed, consisting of nearly all signs seen by two groups of investigators over a 5-year period. Thirty-four items were included in the scale with a possibility of writing in idiosyncratic signs. The scale was shown to have good reliability and validity in studies carried out by both the New York and Boston groups. It is recommended as a suitable instrument for describing the breadth of tardive dyskinesia syndrome and also for quantifying the disorder. A second scale, "the abbreviated dyskinesia scale", contains 13 items which are more global than the items in the original scale. It also has been shown to be both reliable and valid. Its use is suited to situations requiring less extensively detailed assessments.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 115037     DOI: 10.1007/bf00496058

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  13 in total

1.  [Neurological complications of neuroleptic medication].

Authors:  J SIGWALD; D BOUTTIER; S COURVOISIER
Journal:  Rev Neurol (Paris)       Date:  1959-06       Impact factor: 2.607

2.  [4 Cases of facio-bucco-linguo-masticatory dyskinesis of prolonged development following treatment with neuroleptics].

Authors:  J SIGWALD; D BOUTTIER; C RAYMONDEAUD; C PIOT
Journal:  Rev Neurol (Paris)       Date:  1959-06       Impact factor: 2.607

3.  Eye color and tardive dyskinesia.

Authors:  G Gardos; M Sokol; J O Cole; C Sniffin
Journal:  Psychopharmacol Bull       Date:  1976-04

4.  The assessment of tardive dyskinesia.

Authors:  G Gardos; J O Cole; R La Brie
Journal:  Arch Gen Psychiatry       Date:  1977-10

5.  Involuntary movements in a sample of chronic mental patients and their relation to the treatment with neuroleptics.

Authors:  G E Crane; G Paulson
Journal:  Int J Neuropsychiatry       Date:  1967-06

6.  An early clinical and toxicity trial of EX 11-582A in chronic schizophrenia.

Authors:  G M Simpson; B Zoubok; J H Lee
Journal:  Curr Ther Res Clin Exp       Date:  1976-01

7.  An evaluation of papaverine in tardive dyskinesia.

Authors:  G Gardos; J O Cole; C Sniffin
Journal:  J Clin Pharmacol       Date:  1976 May-Jun       Impact factor: 3.126

8.  Lithium in tardive dyskinesia.

Authors:  G M Simpson; M H Branchey; J H Lee; A Voitashevsky; B Zoubok
Journal:  Pharmakopsychiatr Neuropsychopharmakol       Date:  1976-03

9.  Deanol in the treatment of tardive dyskinesia.

Authors:  G M Simpson; A Voitashevsky; M A Young; J H Lee
Journal:  Psychopharmacology (Berl)       Date:  1977-05-09       Impact factor: 4.530

10.  Clozapine in tardive dyskinesia.

Authors:  G M Simpson; J H Lee; R K Shrivastava
Journal:  Psychopharmacology (Berl)       Date:  1978-01-31       Impact factor: 4.530

View more
  53 in total

1.  Positron emission tomography experience with 2-[¹⁸F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-[¹⁸F]FA) in the living human brain of smokers with paranoid schizophrenia.

Authors:  James Robert Brašić; Nicola Cascella; Anil Kumar; Yun Zhou; John Hilton; Vanessa Raymont; Andrew Crabb; Maria Rita Guevara; Andrew G Horti; Dean Foster Wong
Journal:  Synapse       Date:  2011-12-29       Impact factor: 2.562

2.  Tardive dyskinesia: facts the mental health administrator may not know.

Authors:  K M Slaw; J E Kalachnik
Journal:  J Ment Health Adm       Date:  1985

3.  Neurobiological characterization of bipolar affective disorders : a focus on tardive dyskinesia and soft neurological signs in relation to serum dopamine Beta hydroxylase activity.

Authors:  U Goswami; S Basu; U Khastgir; U Kumar; R Chandrasekaran; B N Gangadhar; R Sagar; J S Bapna; S M Channabasavanna; P B Moore; I N Ferrier
Journal:  Indian J Psychiatry       Date:  1998-07       Impact factor: 1.759

Review 4.  Tardive Dyskinesia: Treatment Update.

Authors:  Divya Arya; Tarannum Khan; Adam J Margolius; Hubert H Fernandez
Journal:  Curr Neurol Neurosci Rep       Date:  2019-08-16       Impact factor: 5.081

5.  Diurnal and weekly variation of tardive dyskinesia measured by digital image processing.

Authors:  J K Stanilla; C Büchel; J Alarcon; J de Leon; G M Simpson
Journal:  Psychopharmacology (Berl)       Date:  1996-04       Impact factor: 4.530

Review 6.  Tardive dyskinesia in non-western countries: a review.

Authors:  A K Pandurangi; Y A Aderibigbe
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1995       Impact factor: 5.270

7.  Relations between movement disorders and psychopathology under predominantly atypical antipsychotic treatment in adolescent patients with schizophrenia.

Authors:  Stefan Gebhardt; Fabian Härtling; Markus Hanke; Frank M Theisen; Richard von Georgi; Phillip Grant; Markus Mittendorf; Matthias Martin; Christian Fleischhaker; Eberhard Schulz; Helmut Remschmidt
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-09-14       Impact factor: 4.785

8.  Oral tardive dyskinesia: validation of a measuring device using digital image processing.

Authors:  C Büchel; J de Leon; G M Simpson; W F Gattaz
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

9.  Effects of depot neuroleptics on driving performance in chronic schizophrenic patients.

Authors:  K R Wylie; D J Thompson; H J Wildgust
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-08       Impact factor: 10.154

10.  Risk factors for tardive dyskinesia.

Authors:  S Datta; T P Subhalakshmi; L Jeyaseelan; K Kuruvilla
Journal:  Indian J Psychiatry       Date:  1994-01       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.